OptiNose(OPTN) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

OPTN OptiNose

Watchlist

9.170
0.0000.00%

Close Mar 26 16:00 ET

9.170
0.0000.00%

Post 19:06 ET

92.84MMarket Cap-4.33P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

New Analyst Forecast: $OPTN Given $9.0 Price Target
Quiver Quantitative14:21 ET
OPTINOSE Earnings Results: $OPTN Reports Quarterly Earnings
Quiver Quantitative13:15 ET
OptiNose | 10-K: Annual report
SECMar 26 07:19 ET · Announcements
OptiNose Inc. Q4 Loss Decreases, Beats Estimates
RTTNewsMar 26 07:13 ET
OptiNose | 8-K: Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
SECMar 26 07:05 ET · Announcements
Express News | OptiNose Q4 Income From Operations USD 354 Thousand
ReutersMar 26 07:00 ET

Comments

Trytosaveabit

17 hours ago

Nottoo shabby

$OptiNose (OPTN.US)$ Fourth Quarter 2024 Financial Results
Revenues
The Company reported $22.4 million in net revenue from sales of XHANCE during the three-month period ended December 31, 2024, an increase of 13% compared to $19.9 million during the three-month period ended December 31, 2023. For the twelve-month period ended December 31, 2024, the Company reported $78.2 million in net revenue from sales of XHANCE, an increase of 10% compared to $71.0 million during the twelve-month...

105519319 MYname is

Mar 20 16:28

$OptiNose (OPTN.US)$ 13 opening

Jaguar8

Mar 20 13:01

“Potential consideration of up to $14 per share, including upfront consideration of $9 per share”

$OptiNose (OPTN.US)$

Jaguar8

Mar 20 13:00

NEWS

$OptiNose (OPTN.US)$
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
Wednesday, 19th March at 9:25 pm
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient market
Acquisition advances Paratek's vision to become a multi-product company focused on innovative specialty therapies
Total transaction ...

Jaguar8

Mar 20 05:42

⚫️Watchlist, MARCH 20,2025, Thursday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...

Market Insights

Symbol Mini Chart % Chg

Petroleo Brasileiro SA Petrobras

Unlock the Full List